Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
0.1730
+0.0007 (0.41%)
At close: Jul 1, 2025, 4:00 PM
0.1702
-0.0028 (-1.62%)
After-hours: Jul 1, 2025, 7:15 PM EDT
Beyond Air Revenue
In the fiscal year ending March 31, 2025, Beyond Air had annual revenue of $3.71M with 219.67% growth. Beyond Air had revenue of $1.15M in the quarter ending March 31, 2025, with 145.11% growth.
Revenue (ttm)
$3.71M
Revenue Growth
+219.67%
P/S Ratio
3.16
Revenue / Employee
$60,738
Employees
61
Market Cap
16.05M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
XAIR News
- 14 days ago - Beyond Air, Inc. (XAIR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Beyond Air Stock Dips After Mixed Q4 Results: Here's What To Know - Benzinga
- 14 days ago - Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 15 days ago - Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH - GlobeNewsWire
- 15 days ago - Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings - Benzinga
- 6 weeks ago - Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast - GlobeNewsWire
- 2 months ago - NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism - GlobeNewsWire
- 2 months ago - NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board - GlobeNewsWire